Krystal Biotech (KRYS) PT Raised to $125 at Goldman Sachs
Goldman Sachs analyst Madhu Kumar raised the price target on Krystal Biotech ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)